The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals?
|
|---|---|
| Published in |
Clinical & Experimental Immunology, November 2021
|
| DOI | 10.1093/cei/uxab015 |
| Pubmed ID | |
| Authors |
David Baker, Amy MacDougall, Angray S Kang, Klaus Schmierer, Gavin Giovannoni, Ruth Dobson |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 6 | 27% |
| United States | 3 | 14% |
| Bolivia, Plurinational State of | 1 | 5% |
| Israel | 1 | 5% |
| Belgium | 1 | 5% |
| Canada | 1 | 5% |
| Curaçao | 1 | 5% |
| Unknown | 8 | 36% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 14 | 64% |
| Practitioners (doctors, other healthcare professionals) | 4 | 18% |
| Scientists | 3 | 14% |
| Science communicators (journalists, bloggers, editors) | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 37 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 7 | 19% |
| Researcher | 3 | 8% |
| Student > Ph. D. Student | 3 | 8% |
| Other | 2 | 5% |
| Student > Doctoral Student | 2 | 5% |
| Other | 4 | 11% |
| Unknown | 16 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 7 | 19% |
| Neuroscience | 3 | 8% |
| Biochemistry, Genetics and Molecular Biology | 2 | 5% |
| Agricultural and Biological Sciences | 2 | 5% |
| Nursing and Health Professions | 2 | 5% |
| Other | 6 | 16% |
| Unknown | 15 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2024.
All research outputs
#1,654,338
of 26,103,952 outputs
Outputs from Clinical & Experimental Immunology
#86
of 3,939 outputs
Outputs of similar age
#39,555
of 527,597 outputs
Outputs of similar age from Clinical & Experimental Immunology
#2
of 34 outputs
Altmetric has tracked 26,103,952 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,939 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 527,597 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.